Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea

Asia-Pacific Journal of Clinical Oncology

Volumn 11, Issue 4, 2015, Pages 282-287

  Jo, Jae Cheol ^a   Baek, Jin H ^a   Koh, Su Jin ^a   Kim, Hawk ^a   Min, Young J ^a   Lee, Byung U ^a   Kim, Byung G ^a   Jeong, In D ^a   Cho, Hong R ^a   Kim, Gyu Y ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Adjuvant chemotherapy; Gastric cancer; The elderly

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; DOXIFLURIDINE; FLUOROPYRIMIDINE; FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; OXALIPLATIN; PLATINUM COMPLEX;

ADJUVANT THERAPY; ADVERSE DRUG REACTION; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; DIARRHEA; FEMALE; GASTRECTOMY; HAND FOOT SYNDROME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SIDE EFFECT; SOUTH KOREA; STOMACH CANCER; STOMATITIS; SURVIVAL TIME; UNIVERSITY HOSPITAL; VERY ELDERLY; ADJUVANT CHEMOTHERAPY; CLINICAL TRIAL; MORTALITY; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; FEMALE; GASTRECTOMY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84945466020     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12349     Document Type: Article

References (20)

1. Strong VE, Song KY, Park CH etal. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010; 251: 640-646.
2. Sasako M, Inoue M, Lin JT etal. Gastric cancer working group report. Jpn J Clin Oncol 2010; 40 (Suppl 1): i28-37.
3. Oh DY, Bang YJ. Adjuvant and neoadjuvant therapy for gastric cancer. Curr Treat Options Oncol 2013; 14: 311-320.
4. Sakuramoto S, Sasako M, Yamaguchi T etal. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 1810; 357: 20-2007.
5. Bang YJ, Kim YW, Yang HK etal. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet 2012; 379: 315-321.
6. Kunisaki C, Akiyama H, Nomura M etal. Comparison of surgical outcomes of gastric cancer in elderly and middle-aged patients. Am J Surg 2006; 191: 216-224.
7. Saif MW, Makrilia N, Zalonis A etal. Gastric cancer in the elderly: an overview. Eur J Surg Oncol 2010; 36: 709-717.
8. Jin Y, Qiu MZ, Wang DS etal. Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy. PLoS ONE 2013; 8: e53149.
9. Charlson ME, Pompei P, Ales KL etal. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
10. Satagopan JM, Ben-Porat L, Berwick M etal. A note on competing risks in survival data analysis. Br J Cancer 2004; 91: 1229-1235.
11. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
12. Dudeja V, Habermann EB, Zhong W etal. Guideline recommended gastric cancer care in the elderly: insights into the applicability of cancer trials to real world. Ann Surg Oncol 2011; 18: 26-33.
13. Msika S, Benhamiche AM, Jouve JL etal. Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer 2000; 36: 390-396.
14. Mari E, Floriani I, Tinazzi A etal. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 2000; 11: 837-843.
15. Paoletti X, Oba K, Burzykowski T etal. Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis. JAMA 1729; 303: 37-2010.
16. Hermans J, Bonenkamp JJ, Boon MC etal. Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials. J Clin Oncol 1993; 11: 1441-1447.
17. Janunger KG, Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 2002; 168: 597-608.
18. Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 1999; 35: 1059-1064.
19. Songun I, Putter H, Kranenbarg EM etal. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11: 439-449.
20. Tal S, Guller V, Shavit Y etal. Mortality predictors in hospitalized elderly patients. QJM 2011; 104: 933-938.